Literature DB >> 6131674

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.

J C Sircar, C F Schwender, M E Carethers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131674     DOI: 10.1016/0006-2952(83)90673-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  19 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 2.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

3.  5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine.

Authors:  M B Grisham; D N Granger
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

4.  Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.

Authors:  H Allgayer; J Eisenburg; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Sulphasalazine and experimental stress ulcers.

Authors:  C W Ogle; C H Cho; S Dai
Journal:  Agents Actions       Date:  1985-12

6.  Indomethacin-induced intestinal ulcers in rats: effects of salicylazosulfapyridine and dexamethasone.

Authors:  P Del Soldato; D Foschi; L Varin; S Daniotti
Journal:  Agents Actions       Date:  1985-07

7.  Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

Authors:  C J Hawkey; N K Boughton-Smith; B J Whittle
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

8.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

Authors:  K Lauritsen; J Hansen; P Bytzer; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

9.  Comparison of the effect of oral sulphasalazine, sulphapyridine and 5-amino-salicylic acid on the in vivo antibody response to oral and systemic antigen.

Authors:  P Sheldon; P Pell
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

10.  The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.

Authors:  C H Cho; C W Ogle; E L Sevilla
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.